Press release Communiqué de presse

Share the news     Partagez les nouvelles

Email Facebook LinkedIn Twitter

Press release Communiqué de presse

October 17, 2011 17 October, 2011

Sernova Announces Extension of Terms of Warrants

LONDON, ONTARIO -- October 17, 2011 -- Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE: SVA) announces that it proposes to extend the term of common share purchase warrants that were issued pursuant to a non-brokered private placement of units of the Company (the "Private Placement") on October 30, 2009.

A total of 3,659,000 units (the "Units") were issued in the 2009 Private Placement, each Unit consisted of one common share of the Company (a "Common Share") and one common share purchase warrant of the Company (a "Warrant"), with each Warrant entitling the holder thereof to acquire one additional Common Share at a price of $0.20 per Common Share. The Warrants are scheduled to expire on October 30, 2011. Subject to TSX Venture Exchange approval, the expiration of the 3,659,000 Warrants will be extended to 4:00 p.m. (Pacific Time) on April 30, 2012.

No Warrants have been exercised to date.

About Sernova

Sernova Corp. is a Canadian-based, health- sciences company focused on commercializing medical technologies. Sernova is currently developing a platform technology for a number of serious disease indications, starting with a novel treatment for insulin- dependent diabetes, using the novel Cell Pouch SystemTM and its patented SertolinTM cell technology.

For further information contact: Philip Toleikis, Ph.D., President and CEO Tel: (604) 961-2939

Forward Looking Information This release may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although Sernova believes the expectations expressed in such forward- looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of Sernova's management on the date such statements were made. Sernova expressly disclaims any intention or obligation to update or revise any forward- looking statements whether as a result of new information, future events or otherwise.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.